NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis Risk
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT9426-26-NOI-045255
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN13
Additional Details
Documents1
The Defense Health Agency (DHA), a federal office under the Department of Defense, has issued a Special Notice of Intent to Sole Source for the development of a handheld device designed for the rapid assessment of burn sepsis risk. This procurement activity is classified under NAICS Code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and carries the Product Service Code AN13. The place of performance for this project is Silver Spring, Maryland, United States.
The primary objective of this initiative is to advance medical technology by creating a portable diagnostic tool that can quickly evaluate the risk of sepsis in burn patients. The intended outcome is to enhance clinical decision-making and improve patient outcomes by enabling timely and accurate assessment in both military and civilian healthcare settings. The scope of work likely involves research, development, and prototyping activities within the biotechnology domain, focusing on innovative solutions for burn care and infection risk management.
There are no set-aside requirements associated with this procurement, indicating that it is open to all qualified entities and does not restrict participation based on business size or socioeconomic status. The notice is currently active, and interested parties are encouraged to review the attached documentation for further details regarding the project requirements and deliverables.
The contracting entity for this opportunity is the Defense Health Agency, with primary and secondary points of contact provided for inquiries: Nicole Applegate ([email protected]) and Lance Nowell ([email protected]). The notice was posted on September 18, 2026, with a response deadline of November 2, 2026.
Contractors evaluating this opportunity should note the focus on biotechnology research and development, the absence of set-aside restrictions, and the specialized nature of the deliverable—a handheld diagnostic device for burn sepsis risk assessment. The project will be performed in Silver Spring, Maryland, and will remain under the oversight of the Defense Health Agency throughout its lifecycle. For comprehensive information and submission guidelines, refer to the official notice and its attachment via the SAM.gov link provided.